8.28
0.01 (0.12%)
| Penutupan Terdahulu | 8.27 |
| Buka | 8.24 |
| Jumlah Dagangan | 21,634 |
| Purata Dagangan (3B) | 67,341 |
| Modal Pasaran | 478,716,576 |
| Harga / Pendapatan (P/E TTM) | 23.66 |
| Harga / Pendapatan (P/E Ke hadapan) | 15.13 |
| Harga / Jualan (P/S) | 2.64 |
| Harga / Buku (P/B) | 1.78 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 May 2026 |
| Hasil Dividen (DY TTM) | 3.02% |
| Margin Keuntungan | 9.60% |
| Margin Operasi (TTM) | 17.71% |
| EPS Cair (TTM) | 0.280 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 16.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 67.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.41% |
| Nisbah Semasa (MRQ) | 3.30 |
| Aliran Tunai Operasi (OCF TTM) | 46.06 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 36.83 M |
| Pulangan Atas Aset (ROA TTM) | 4.14% |
| Pulangan Atas Ekuiti (ROE TTM) | 6.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Kamada Ltd. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.33 |
|
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 7.22% |
| % Dimiliki oleh Institusi | 48.70% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Y.D. More Investments Ltd | 31 Dec 2025 | 289,382 |
| Huntleigh Advisors, Inc. | 31 Dec 2025 | 149,374 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Hasil Dividen (DY TTM) | 3.02% |
| Purata Hasil Dividen 1T | 2.83% |
| Jangkaan Pembayaran Dividen Seterusnya | Apr 2027 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 23 Mar 2026 | 11 Mar 2026 | 07 Apr 2026 | 0.25 Tunai |
| 17 Mar 2025 | 05 Mar 2025 | 07 Apr 2025 | 0.2 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2026 | 0.250 | 1 | 3.02 |
| 2025 | 0.200 | 1 | 2.83 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |